Evonik rejects BASF takeover approach, opts to stay independent
Evonik Industries rejected a takeover approach from BASF, opting to remain independent. BASF had proposed a valuation of over €11 billion, up from €10.3 billion, with commitments to preserve jobs and production sites. Evonik's board reviewed the offer but decided against negotiations, reaffirming its strategic independence.
How this was made
The 30-second read
Why it matters
The rejection removes a potential premium for Evonik and signals a setback for BASF's expansion plans, likely pressuring both stocks.
Market read
Significant M&A news in the European chemicals sector that could affect sector indices and peer stocks.
What to watch
Regulatory approval risk, integration challenges, and valuation concerns could affect the ultimate outcome.
Background
Evonik Industries announced it will not pursue takeover talks with BASF after reviewing a proposal valued at over €11 bn.
Ticker impact
BASF's proposed €11 bn takeover of Evonik was turned down, potentially dampening BASF's stock on the failed bid.
moderate downside as market reacts to the failed acquisition attempt
A rejected bid can be viewed as a setback for BASF's growth strategy, pressuring its stock.
Market effects
German chemicals sector may experience heightened volatility and reassessment of peer valuations.
European markets, especially the DAX, could react to the M&A news across chemical stocks.
The deal draws global attention to M&A activity in the chemicals industry.
Counterpoint
BASF might revisit or improve its offer, creating upside potential if negotiations resume.
Key entities
- companyEvonik Industries AG
German chemicals producer that rejected BASF's takeover approach.
- companyBASF SE
German chemicals giant that made a takeover proposal for Evonik.
